Emmanuel Krakaris's most recent trade in Augmedix Inc was a trade of 9,375 Common Stock done . Disclosure was reported to the exchange on Aug. 15, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Augmedix Inc | Emmanuel Krakaris | Director, PRESIDENT, CEO, AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 9,375 | 68,273 | - | - | Common Stock | |
| Augmedix Inc | Emmanuel Krakaris | Director, PRESIDENT, CEO, AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 9,375 | 131,250 | - | - | Restricted Stock Units | |
| Augmedix Inc | Emmanuel Krakaris | Director, PRESIDENT, CEO, AND SECRETARY | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.27 per share. | 15 Aug 2024 | 3,525 | 64,748 | - | 2.3 | 8,002 | Common Stock |
| Augmedix Inc | Emmanuel Krakaris | Director, PRESIDENT, CEO, AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 9,375 | 62,426 | - | - | Common Stock | |
| Augmedix Inc | Emmanuel Krakaris | Director, PRESIDENT, CEO, AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 9,375 | 140,625 | - | - | Restricted Stock Units | |
| Augmedix Inc | Emmanuel Krakaris | Director, PRESIDENT, CEO, AND SECRETARY | Sale of securities on an exchange or to another person at price $ 1.19 per share. | 15 May 2024 | 3,528 | 58,898 | - | 1.2 | 4,198 | Common Stock |
| Augmedix Inc | Emmanuel Krakaris | Director, PRESIDENT, CEO, AND SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 150,000 | 150,000 | - | - | Restricted Stock Units | |
| Augmedix Inc | Emmanuel Krakaris | Director, PRESIDENT, CEO, AND SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2023 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
| Augmedix Inc | Emmanuel Krakaris | Director, PRESIDENT, CEO, AND SECRETARY | Purchase of securities on an exchange or from another person at price $ 3.20 per share. | 24 Nov 2021 | 15,551 | 53,051 | - | 3.2 | 49,763 | Common Stock |
| Augmedix Inc | Emmanuel Krakaris | Director, PRESIDENT, CEO, AND SECRETARY | Purchase of securities on an exchange or from another person at price $ 4.00 per share. | 28 Oct 2021 | 37,500 | 37,500 | - | 4 | 150,000 | Common Stock |